Frederik Stevenaert

Frederik Stevenaert has been working in the scientific field since 2000, when they began their PhD at Ghent University. Following their PhD, they were a Post Doc Fellow at Schering Plough Biopharma - DNAX Research Institute from 2006 to 2008. Frederik then worked as a Scientist at Ablynx from 2008 to 2011, and a Senior Scientist at Janssen Pharmaceutical Companies (Johnson & Johnson) from 2011 to 2016. Currently, they are a Principal Scientist at Aelin Therapeutics, a position they have held since 2022.

Frederik Stevenaert received a Master's degree in Biotechnology from Ghent University between 1995 and 1999.